[Retracted] The Value of Left Atrial Volume Changes in Predicting Cardiotoxicity in Patients Undergoing Anthracycline Chemotherapy

Table 3

Table of echocardiographic parameters at different time points in patients with and without cardiotoxicity.

Index	Group	T0	T1	T2	T3	F value	P value
LAVmin (mL)	Cardiotoxicity (N = 10)	16.83 ± 2.07	17.93 ± 2.51	20.62 ± 1.47	22.94 ± 1.91	5.201	0.007
	Noncardiotoxicity (N = 43)	16.13 ± 3.92	16.63 ± 3.29	18.39 ± 1.84	19.84 ± 2.72
LAVmax (mL)	Cardiotoxicity (N = 10)	38.82 ± 4.96	39.11 ± 5.23	40.28 ± 5.28	42.82 ± 6.02	4.713	0.011
	Noncardiotoxicity (N = 43)	36.18 ± 5.29	38.72 ± 6.28	39.13 ± 5.65	40.89 ± 5.39
LAVprep (mL)	Cardiotoxicity (N = 10)	25.92 ± 5.29	26.29 ± 4.68	28.83 ± 3.17	29.99 ± 5.53	2.934	0.049
	Noncardiotoxicity (N = 43)	24.88 ± 4.02	25.18 ± 3.79	26.69 ± 4.03	26.11 ± 4.18
LAEF (%)	Cardiotoxicity (N = 10)	54.65 ± 8.34	53.52 ± 7.75	52.42 ± 8.25	51.54 ± 8.27	1.243	0.295
	Noncardiotoxicity (N = 43)	55.65 ± 9.43	54.54 ± 8.43	54.14 ± 9.65	53.83 ± 8.42

Note: compared with noncardiotoxicity group, .